Thomas RS - Search Results

1

A physiologically based pharmacodynamic analysis of hepatic foci within a medium-term liver bioassay using pentachlorobenzene as a promoter and diethylnitrosamine as an initiator.

Thomas RS, Conolly RB, Gustafson DL, Long ME, Benjamin SA, Yang RS. Thomas RS, et al. Toxicol Appl Pharmacol. 2000 Jul 15;166(2):128-37. doi: 10.1006/taap.2000.8959. Toxicol Appl Pharmacol. 2000. PMID: 10896854

2

Physiologically based pharmacokinetic/pharmacodynamic modeling of chemical mixtures and possible applications in risk assessment.

el-Masri HA, Thomas RS, Benjamin SA, Yang RS. el-Masri HA, et al. Among authors: thomas rs. Toxicology. 1995 Dec 28;105(2-3):275-82. doi: 10.1016/0300-483x(95)03222-2. Toxicology. 1995. PMID: 8571364

3

The use of physiologically-based pharmacokinetic/pharmacodynamic dosimetry models for chemical mixtures.

Yang RS, el-Masri HA, Thomas RS, Constan AA. Yang RS, et al. Among authors: thomas rs. Toxicol Lett. 1995 Dec;82-83:497-504. doi: 10.1016/0378-4274(95)03579-6. Toxicol Lett. 1995. PMID: 8597101 Review.

4

Physiologically based pharmacokinetic/pharmacodynamic modeling of the toxicologic interaction between carbon tetrachloride and Kepone.

el-Masri HA, Thomas RS, Sabados GR, Phillips JK, Constan AA, Benjamin SA, Andersen ME, Mehendale HM, Yang RS. el-Masri HA, et al. Among authors: thomas rs. Arch Toxicol. 1996;70(11):704-13. doi: 10.1007/s002040050331. Arch Toxicol. 1996. PMID: 8896716

5

Enhanced regional expression of glutathione S-transferase P1-1 with colocalized AP-1 and CYP 1A2 induction in chlorobenzene-induced porphyria.

Thomas RS, Gustafson DL, Ramsdell HS, el-Masri HA, Benjamin SA, Yang RS. Thomas RS, et al. Toxicol Appl Pharmacol. 1998 May;150(1):22-31. doi: 10.1006/taap.1998.8385. Toxicol Appl Pharmacol. 1998. PMID: 9630449

6

Use of a medium-term liver focus bioassay to assess the hepatocarcinogenicity of 1,2,4,5-tetrachlorobenzene and 1,4-dichlorobenzene.

Gustafson DL, Coulson AL, Feng L, Pott WA, Thomas RS, Chubb LS, Saghir SA, Benjamin SA, Yang RS. Gustafson DL, et al. Among authors: thomas rs. Cancer Lett. 1998 Jul 3;129(1):39-44. doi: 10.1016/s0304-3835(98)00078-0. Cancer Lett. 1998. PMID: 9714333

7

Evidence for hepatocarcinogenic activity of pentachlorobenzene with intralobular variation in foci incidence.

Thomas RS, Gustafson DL, Pott WA, Long ME, Benjamin SA, Yang RS. Thomas RS, et al. Carcinogenesis. 1998 Oct;19(10):1855-62. doi: 10.1093/carcin/19.10.1855. Carcinogenesis. 1998. PMID: 9806169

8

Comparative hepatocarcinogenicity of hexachlorobenzene, pentachlorobenzene, 1,2,4,5-tetrachlorobenzene, and 1,4-dichlorobenzene: application of a medium-term liver focus bioassay and molecular and cellular indices.

Gustafson DL, Long ME, Thomas RS, Benjamin SA, Yang RS. Gustafson DL, et al. Among authors: thomas rs. Toxicol Sci. 2000 Feb;53(2):245-52. doi: 10.1093/toxsci/53.2.245. Toxicol Sci. 2000. PMID: 10696772

9

A clonal growth model: time-course simulations of liver foci growth following penta- or hexachlorobenzene treatment in a medium-term bioassay.

Ou YC, Conolly RB, Thomas RS, Xu Y, Andersen ME, Chubb LS, Pitot HC, Yang RS. Ou YC, et al. Among authors: thomas rs. Cancer Res. 2001 Mar 1;61(5):1879-89. Cancer Res. 2001. PMID: 11280742

10

The application of physiologically based pharmacokinetic/pharmacodynamic (PBPK/PD) modeling for exploring risk assessment approaches of chemical mixtures.

Yang RS, el-Masri HA, Thomas RS, Constan AA, Tessari JD. Yang RS, et al. Among authors: thomas rs. Toxicol Lett. 1995 Sep;79(1-3):193-200. doi: 10.1016/0378-4274(95)03370-z. Toxicol Lett. 1995. PMID: 7570656 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

295 results

Search Page

Filters